Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1NET 1Head & Neck 1Endocrine 1Dermatologic 1CNS 1Breast 1

Conditions

Uveal Melanoma 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pheochromocytoma 1Paraganglioma 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Melanoma 1Breast Neoplasms 1Adrenocortical Carcinoma 1Adenoma, Islet Cell 1Adenocarcinoma of Lung 1

Interventions

vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1sargramostim 1mercaptoundecahydrododecaborate 1fludarabine phosphate 1entinostat 1avelumab 1aldesleukin 1Trastuzumab 1Surgical Procedures, Operative 1Specimen Handling 1Semaxinib 1Ritonavir 1Radiotherapy 1Photochemotherapy 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Interleukin-13 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Gefitinib 1Fluorodeoxyglucose F18 1Fentanyl 1Docetaxel 1Cyclophosphamide 1Congresses as Topic 1Biopsy 14-boronophenylalanine-fructose 12-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Interleukin-13 × Endocrine × Clear all
NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Stanford University

Phase 1 Recruiting
18 enrolled
BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡